Medios AG

Medios AG

MEDOF

$50.00

Updated: 23/09/2026, 02:38:44

Market Cap
$1.28B
Sector
Healthcare
Industry
Medical - Distribution
Country
DE
Stock valuation chart
One-year closing share-price history for MEDOF
Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.

USD
OTC
CEO: Thomas Meier
Employees: 993
https://medios.group
Asset Summaries
Latest generated summaries for MEDOF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for MEDOF.
Share price
$50.00
Market cap
$1.28B
Exchange
OTC
Currency
USD
CEO
Thomas Meier
Employees
993
IPO date
10/11/2021
Beta
1.296
Last dividend
$0.00
Day range
$13.64 – $50.00
52-week range
$13.64 – $50.00
1-day performance
0.00%
1-year performance
266.57%
Current drawdown (1Y)
0.00%
CIK
N/A
CUSIP
N/A
ISIN
DE000A1MMCC8
Created
07/12/2025, 05:12:58
Last update
23/09/2026, 02:38:44

Track Medios AG with an AI analyst

See which prediction-market events move MEDOF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to MEDOF from your Railway `news_articles` table.

No news found for this symbol.